A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

May 16, 2017

Conditions
Non-small Cell Lung Cancer(NSCLC)
Interventions
DRUG

AT13387

HSP90 inhibitor

DRUG

Crizotinib

ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene1, receptor tyrosine kinase) inhibitor

Trial Locations (65)

10032

Columbia University Medical Center, New York

10461

Montefiore Medical Center, The Bronx

13273

Institut Paoli-Calmettes, Marseille

14033

CHU de Caen-Hopital Cote de Nacre, Caen

19107

Thomas Jefferson University, Philadelphia

19713

Christiana Hospital, Newark

22031

Virginia Cancer Specialists, Fairfax

25030

Centre Hospitalier Regional Universitaire Besancon, Besançon

27409

Cone Health Cancer Center, Greensboro

27710

Duke University Medical Center, Durham

28050

Centro Integral Oncologico Clara Campal, Madrid

29010

Hospital Regional Universitario de Malaga, Málaga

32804

Florida Hospital Cancer Institute, Orlando

37203

Sarah Cannon Research Institute, Nashville

38043

Centre Hospitalier de Grenoble, Grenoble

38138

The West Clinic, Germantown

43210

Ohio State University Medical Center, Columbus

44195

Cleveland Clinic, Cleveland

45242

Oncology Hematology in Cincinnati, Cincinnati

45267

University of Cincinnati Cancer Institute, Cincinnati

46202

Indiana University Melvin and and Bren Simon Cancer Center, Indianapolis

48109

University of Michigan Medical Center, Ann Arbor

48201

Barbara Ann Karmanos Cancer Institute, Detroit

53579

University of Wisconsin-Carbone Cancer Center, Madison

55905

Mayo Clinic-Rochester, Rochester

59037

CHRU de Lille, Lille

60611

Northwestern University The Feinberg School of Medicine, Chicago

60637

University of Chicago, Chicago

63110

Washington University School of Medicine, St Louis

68198

University of Nebraska Medical Center Eppley Cancer Center, Omaha

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

75020

Hopital Tenon, Paris

75390

University of Texas Southwestern Medical Center, Dallas

80045

University of Colorado Denver, Aurora

85259

Mayo Clinic-Scottsdale, Scottsdale

90033

USC Norris Comprehensive Cancer Center, Los Angeles

90095

UCLA Medical Center, Los Angeles

90603

Innovative Clinical Research Institute, Whittier

92123

Sharp Clinical Oncology Research-Sharp Memorial Hospital, San Diego

94010

Hopital Saint Antoine, Créteil

94800

Institut Gustave Roussy, Villejuif

97213

Providence Portland Medical Center, Portland

98104

Swedish Cancer Institute, Seattle

98109

University of Washington Medical Center, Seattle

92093-0698

University of California, San Diego Medical Center, La Jolla

06519

Yale University School of Medicine-Yale Cancer Center, New Haven

33612-9497

H. Lee Moffitt Cancer Center & Research Institute, Tampa

03756

Dartmouth Hitchcock Medical Center, Lebanon

17033-0850

The Pennsylvania State University-Penn State, Hershey

B3H 1V7

Atlantic Clinical Cancer Research Unit, Halifax

H3A 1A1

McGill University Health Center, Montreal, Quebec

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie De Quebec, Sainte-Foy, Quebec

M5G 2M9

Princess Margaret Hospital, Toronto, Ontario

R3E OV9

Cancer Care Manitoba, Winnipeg

31 059

CHU Toulouse-Hopital Larrey, Toulouse

362-711

Chungbuk National University Hospital, Cheongju-si

442-723

The Catholic University of Korea, St. Vincent's Hospital, Gyeonggi-do

519-809

Chonnam National University Hwasun Hospital, Hwasun-gun Jeonnam

410-769

National Cancer Center, Korea

463-707

Seoul National University Bundang Hospital, Seongnam

120-752

Severance Hospital, Yonsei University Health System, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Asan Medical Center, Seoul

08916

Hospital Germans Trias i Pujol, Badalona

08028

Hospital Universitari Quiron Dexeus Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY